• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    OncoMed Pharmaceuticals, Inc. (OMED)

    -NasdaqGS
    22.86 Down 0.22(0.95%) 4:00PM EST
    |After Hours : 22.86 0.00 (0.00%) 5:18PM EST
    Add to Portfolio
    Prev Close:23.08
    Open:22.86
    Bid:21.11 x 1000
    Ask:34.64 x 1000
    1y Target Est:42.20
    Beta:1.637
    Next Earnings Date:N/A
    Day's Range:22.41 - 23.60
    52wk Range:16.57 - 39.50
    Volume:200,144
    Avg Vol (3m):164,148
    Market Cap:681.96M
    P/E (ttm):N/A
    EPS (ttm):-1.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OMED

    Comparison

    Symbol% ChgMkt Cap
    OMEDDown 0.95%681.96M
    STMLUp 3.27%200.61M
    VSTMDown 5.32%189.03M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):13.76
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.37
    Quarterly EPS Est (Dec-14) :-0.27
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem Cells (CSCs). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback